11/29/2021
https://www.congress.gov...
"Proxy advisory firms' outsized influence on emerging companies can be uniquely damaging to small, growing biotechs."
"I am encouraged that the subcommittee is holding today's hearing to examine the impact of such roadblocks on smaller public companies."
"We must have up to date information and a coordinated strategy to disrupt its funding sources."
"This is why Chairman Fitzpatrick and I offered an amendment to the NDAA to direct the Secretary of Defense to establish a whole of government strategy to destroy their funding networks."